Document is current
Any future updates will be listed below
-
Authors
Petracci, Elisabetta
Pasini, Luigi
Urbini, Milena
Felip, Enriqueta
Stella, Franco
Davoli, Fabio
Salvi, Maurizio
Beau-Faller, Michele
Tebaldi, Michela
Azzali, Irene
Canale, Matteo
Solli, Piergiorgio
Lai, Giulia
Amat, Ramon
Carbonell, Caterina
Falcoz, Pierre-Emmanuel
Martinez-Marti, Alex
Pencreach, Erwan
Delmonte, Angelo
Crinò, Lucio
Ulivi, Paola
- License Information
-
More Information
Article History
Received: 12 April 2024
Accepted: 8 August 2024
First Online: 22 August 2024
Declarations
:
: Study protocol was approved by the independent ethics committees (IRST-IRCCS: CEROM N.0003097/2018 of 24/04/2018; S.Orsola-Malpighi Hospital: AVEC N.704/2018/OSS/AUSLBO; Hospital Vall d’Hebron/VHIO: PR(AG)188/2018; CPP Ile-de-France, Protocole 22–2019; CHU De Strasburg). All patients provided written informed consent.
: All authors consent to publication.
: Dr. Felip received grants from ABBVIE, AMGEN, ASTRA ZENECA, BAYER, BEIGENEBOEHRINGER INGELHEIM, BRISTOL MYERS SQUIBB, ELI LILLY, F. HOFFMANN-LA ROCHE, GENENTECH, GILEAD, GLAXO SMITH KLINE, JANSSEN, MEDICAL TRENDS, MEDSCAPE, MERCK SERONO, MERCK SHARP & DOHME, NOVARTIS, PEERVOICE, PEPTOMYC, PFIZER, REGENERON, SANOFI, TAKEDA, TOUCH ONCOLOGY, TURNING POINT, DAIICHI SANKYO. No disclosures were reported by the other authors.
